April 28 (Reuters) – Celgene Execs Say Otezla Continues To
Grow At Similar Rate After Novartis’ Cosentyx Launch – Conf Call

The post BRIEF-Celgene says 2020 Revlimid forecast is conservative: conf call appeared first on NASDAQ.